Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Chest|December 15, 2010
Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertensionArun Sachdev, Hector R Villarraga, Robert P Frantz, et al.Chest|June 19, 2010
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary RegistriesAdaani E Frost, David B Badesch, Robyn J Barst, et al.Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.Journal of the American College of Cardiology|December 21, 2013
Updated treatment algorithm of pulmonary arterial hypertensionNazzareno Galiè, Paul A Corris, Adaani Frost, et al.Journal of the American College of Cardiology|November 14, 2009
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertensionRonald J Oudiz, Nazzareno Galiè, Horst Olschewski, et al.Chest|August 17, 2013
Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainageEric R Fenstad, Rachel J Le, Lawrence J Sinak, et al.Circulation|May 29, 2008
Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2Nazzareno Galiè, Horst Olschewski, Ronald J Oudiz, et al.Chest|October 20, 2009
Pulmonary arterial hypertension: baseline characteristics from the REVEAL RegistryDavid B Badesch, Gary E Raskob, C Greg Elliott, et al.The European Respiratory Journal|April 4, 2015
Validation of two predictive models for survival in pulmonary arterial hypertensionOlivier Sitbon, Raymond L Benza, David B Badesch, et al.Journal of Cardiovascular Pharmacology|January 28, 2003
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertensionVallerie V McLaughlin, Sean P Gaine, Robyn J Barst, et al.Pageof 8